What are cancer patients willing to pay for prophylactic epoetin alfa?—A cost‐benefit analysis

Saved in:
Bibliographic Details
Published in:Cancer 1999-09, Vol.86 (6), p.1095-1096
Main Authors: Orhan, Bülent, Yalçin, Şuayib
Format: Article
Language:English
Subjects:
Anemia - prevention & control
Antineoplastic Agents - adverse effects
Cost-Benefit Analysis
Epoetin Alfa
Erythropoietin - economics
Erythropoietin - therapeutic use
Humans
Neoplasms - drug therapy
Neoplasms - economics
Recombinant Proteins
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0008-543X
1097-0142
DOI:10.1002/(SICI)1097-0142(19990915)86:6<1095::AID-CNCR28>3.0.CO;2-K